Efficacy and Safety of Aumolertinib as Adjuvant Therapy in Resectable Stage I NSCLC with High-grade Patterns and EGFR Mutations (APPOINT)

被引:0
|
作者
Han, B. [1 ]
Fang, W. [1 ]
Chen, C. [2 ]
Zhang, W. [1 ]
Zhang, B. [1 ]
Yao, F. [1 ]
Shi, J. [1 ]
Yue, D. [3 ]
Qi, Y. [4 ]
Zhu, Z. [5 ]
Xie, J. [6 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Chest Hosp, Shanghai, Peoples R China
[2] Shanghai Pulm Hosp, Shanghai, Peoples R China
[3] Tianjin Med Univ, Canc Inst Hosp, Tianjin, Peoples R China
[4] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[5] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Hangzhou, Peoples R China
[6] Putian Coll, Affiliated Hosp, Putian, Peoples R China
关键词
aumolertinib; high-grade patterns; NSCLC;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.27-09
引用
收藏
页码:S287 / S287
页数:1
相关论文
共 50 条
  • [31] Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia
    Overholt, Bergein F.
    Wang, Kenneth K.
    Burdick, J. Steven
    Lightdale, Charles J.
    Kimmey, Michael
    Nava, Hector R.
    Sivak, Michael V., Jr.
    Nishioka, Norman
    Barr, Hugh
    Marcon, Norman
    Pedrosa, Marcos
    Bronner, Mary P.
    Grace, Michael
    Depot, Michelle
    GASTROINTESTINAL ENDOSCOPY, 2007, 66 (03) : 460 - 468
  • [32] Patterns of Care for Adjuvant Therapy in High-Intermediate-Risk Stage I Endometrial Cancer
    McGunigal, M.
    Liu, J. T.
    Chadha, M.
    Gupta, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E316 - E316
  • [33] Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
    Zuniga, R. M.
    Torcuator, R.
    Jain, R.
    Anderson, J.
    Doyle, T.
    Ellika, S.
    Schultz, L.
    Mikkelsen, T.
    JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (03) : 329 - 336
  • [34] Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
    R. M. Zuniga
    R. Torcuator
    R. Jain
    J. Anderson
    T. Doyle
    S. Ellika
    L. Schultz
    T. Mikkelsen
    Journal of Neuro-Oncology, 2009, 91 : 329 - 336
  • [35] Treatment With Adjuvant Pelvic Radiation Therapy ± Vaginal Brachytherapy in Patients With High-Risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-Grade Endometrioid Carcinoma
    Nagar, H.
    Yan, W.
    Parashar, B.
    Nori, D.
    Chao, K.
    Christos, P.
    Gupta, D.
    Holcomb, K.
    Caputo, T.
    Wemicke, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S492 - S492
  • [36] A phase II study of surgical excision, temozolomide, radiotherapy, and anti-EGFR radioimmunotherapy (EXTRA) as adjuvant therapy in high-grade gliomas
    Daugherty, Larry C.
    Fisher, Brandon J.
    Morales, Steven
    Kim, Ji
    Li, Linna
    Quang, Tony S.
    Emrich, Jacqueline
    Yaeger, Theodore
    Jenrette, Joseph M.
    Cohen, Steven
    Komarnicky, Lydia T.
    Tzou, Katherine
    Peterson, Jennifer
    Brady, Luther W.
    JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (04) : 347 - 353
  • [37] A Phase II Study of Surgical Excision, Temozolomide, Radiotherapy, and Anti-EGFR Radioimmunotherapy (EXTRA) as Adjuvant Therapy in High-grade Gliomas
    Daugherty, L. C.
    Morales, S.
    Fisher, B.
    Li, L.
    Kim, J.
    Quang, T.
    Emrich, J.
    Yaeger, T.
    Komarnicky, L.
    Brady, L. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S180 - S180
  • [38] Furmonertinib as Adjuvant Therapy in Postoperative EGFR-Mutated Stage IB-IIA NSCLC with High-Risk Pathological Factors
    Li, X. -L.
    Wang, X.
    Fan, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S377 - S377
  • [39] Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas
    Lakshmi Nayak
    John de Groot
    Jeffrey S. Wefel
    Timothy F. Cloughesy
    Frank Lieberman
    Susan M. Chang
    Antonio Omuro
    Jan Drappatz
    Tracy T. Batchelor
    Lisa M. DeAngelis
    Mark R. Gilbert
    Kenneth D. Aldape
    Alfred W. K. Yung
    Joy Fisher
    Xiaobu Ye
    Alice Chen
    Stuart Grossman
    Michael Prados
    Patrick Y. Wen
    Journal of Neuro-Oncology, 2017, 132 : 181 - 188
  • [40] Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas
    Nayak, Lakshmi
    de Groot, John
    Wefel, Jeffrey S.
    Cloughesy, Timothy F.
    Lieberman, Frank
    Chang, Susan M.
    Omuro, Antonio
    Drappatz, Jan
    Batchelor, Tracy T.
    DeAngelis, Lisa M.
    Gilbert, Mark R.
    Aldape, Kenneth D.
    Yung, Alfred W. K.
    Fisher, Joy
    Ye, Xiaobu
    Chen, Alice
    Grossman, Stuart
    Prados, Michael
    Wen, Patrick Y.
    JOURNAL OF NEURO-ONCOLOGY, 2017, 132 (01) : 181 - 188